Building the Caribbean's pharmaceutical gateway.
97% of Caribbean medicines are imported. BPI is building the manufacturing capacity, supply chain, and regulatory infrastructure to change that.
"This has been a major achievement for a small state like Barbados, to be able to position itself at the centre of the Americas as a location for the development of a pharmaceutical industry."
Barbados Pharmaceutical Inc. is building the gateway that connects Caribbean demand with global pharmaceutical expertise.
Four Strategic Priorities
Each one a deliberate step toward a Caribbean that manufactures, distributes, and regulates its own medicines.
Attract & Facilitate Investment
Giving global capital a clear pathway into the Caribbean pharmaceutical market.
Build & Incubate Capacity
Moving strategic projects from concept to execution.
Strengthen Regional Supply Chains
Building the trade corridors and distribution infrastructure the Caribbean depends on.
Build the Ecosystem Foundations
Developing the regulatory, workforce, and research foundations for a permanent sector.
Shifting Trade Prowess in Favour of the Global South
BPI is building across six sectors, each one a structural component of the Caribbean's pharmaceutical future.
01: Market Access & Trade Development
Opening pharmaceutical trade routes across CARICOM, Latin America, Africa, and the Global South.
02: Workforce & Talent Development
Building the skilled workforce Caribbean pharmaceutical production depends on.
03: Research & Development
Establishing Barbados as a credible site for pharmaceutical research and technology transfer.
04: Innovation & Technology
Creating the conditions for pharmaceutical innovation to take root and scale.
05: Regulatory Development & Policy
Building the regulatory framework that gives investors and manufacturers confidence to commit.
06: Investment & Financing
Connecting viable projects to the right capital at the right stage.
01: Market Access & Trade Development
Opening pharmaceutical trade routes across CARICOM, Latin America, Africa, and the Global South.
02: Workforce & Talent Development
Building the skilled workforce Caribbean pharmaceutical production depends on.
03: Research & Development
Establishing Barbados as a credible site for pharmaceutical research and technology transfer.
04: Innovation & Technology
Creating the conditions for pharmaceutical innovation to take root and scale.
05: Regulatory Development & Policy
Building the regulatory framework that gives investors and manufacturers confidence to commit.
06: Investment & Financing
Connecting viable projects to the right capital at the right stage.
"Perhaps the biggest game changer since we have come to office is addressing the issue of pharmaceutical equity and creating a platform for jobs, investment and earnings for a pharmaceutical industry in Barbados for the first time."
Rt. Hon. Mia Amor Mottley, Prime Minister of Barbados
BPI is the institution built to deliver on that mandate, reducing pharmaceutical import dependency and building health sovereignty across the Caribbean.
Initiatives
AMA IV Fluids Manufacturing — Grantley Adams Industrial Estate
The first Africa–Caribbean pharmaceutical trade corridor. 12 million units annually. A corridor, not a pilot.
PAHO Regional Supply Hub
Serving 40+ countries across the Caribbean and Latin America.
EU PharmaNext
€3M transatlantic pharmaceutical investment bridge.
BMPRA Regulatory Development
Barbados's own standard-holder, built with WHO and PAHO.